Drug data last refreshed 3h ago · AI intelligence enriched 6d ago
Trovan Preservative Free is an injectable fluoroquinolone antibiotic (alatrofloxacin mesylate) approved in 1997 for serious bacterial infections. It is a prodrug that is converted in vivo to trovafloxacin, a broad-spectrum quinolone with activity against gram-positive, gram-negative, and anaerobic organisms. The preservative-free formulation is designed for patients requiring parenteral antibiotic therapy without additive exposure.
As an LOE-approaching injectable antibiotic with minimal linked job activity, this product likely operates with a lean, specialized team focused on managed care and hospital distribution.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Trovan Preservative Free offers limited career growth opportunities given the product's LOE status and minimal linked job openings (zero reported). Roles on this team are typically maintenance-focused, supporting hospital contracting, compliance, and managed decline rather than market expansion or innovation.
Worked on TROVAN PRESERVATIVE FREE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.